Contract Win (0894D)
10 Mai 2012 - 3:00PM
UK Regulatory
TIDMRVG
RNS Number : 0894D
Retroscreen Virology Group PLC
10 May 2012
Retroscreen Virology Group plc ("Retroscreen" or the
"Company")
Contract Win
The Board of Directors of Retroscreen, the AIM-quoted viral
challenge quarantine and "Virometrics" specialist, is pleased to
announce the signing of a Viral Challenge Model ("VCM") contract
with a major US-based biotechnology company for the provision of an
influenza challenge study. The contract, which is valued at GBP3.9m
and had previously been under a Start Up Agreement, represents a
significant milestone in the Company's growth.
Kym Denny, Chief Executive Officer, commented, "We are delighted
to be working with such an innovative client on the development of
their novel product. This contract is testament to the
pharmaceutical industry's increasing awareness of the benefits of
the VCM in accelerating drug development and product
decision-making."
Enquiries:
Retroscreen Virology Group plc +44 207 756 1300
Kym Denny (CEO)
Graham Yeatman (FD)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
This information is provided by RNS
The company news service from the London Stock Exchange
END
CNTBKKDKBBKDAPD
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
